Sepsis is a highly lethal clinical syndrome characterized by a systemic inf
lammatory response to infection. Fever, a non-specific acute-phase response
, has been associated with improved survival and shortened disease duration
in non-life-threatening infections. However, the influence of fever and th
e effects of antipyresis in patients with sepsis has not been prospectively
studied in humans. This payer reviews the state of our knowledge concernin
g the biological effects of fever in infected hosts and the influence of fe
ver and antipyretic therapy on survival during sepsis in experimental model
s and in man. (C) 2000 Editions scientifiques et medicales Elsevier SAS.